FUNCTIONAL LIVER IMAGING WITH TC-99 M-GALACTOSYLNEOGLYCOALBUMIN (NGA) IN ALCOHOLIC LIVER-CIRRHOSIS AND LIVER FIBROSIS

被引:20
作者
VIRGOLINI, I
MULLER, C
ANGELBERGER, P
HOBART, J
BERGMANN, H
SINZINGER, H
机构
[1] Department of Nuclear Medicine, Seibersdorf
[2] Department of Gastroenterology and Hepatology, University of Vienna, Seibersdorf
[3] Chemical Institute, Research Center, Seibersdorf
关键词
D O I
10.1097/00006231-199106000-00005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Synthesis of Tc-99m-galactosyl-neoglycoalbumin (Tc-99m-NGA), a recently described new radioligand with high specificity for hepatic binding protein (HBP), a galactose-residue specific receptor on hepatocytes, was carried out by covalent coupling of 2-imino-2-methoxyethyl-1-thio-beta-D-galactopyranoside to the primary amino groups of human serum albumin. NGA was purified by ultrafiltration and size exclusion high-pressure liquid chromatography (HPLC). Using a computer-based simulation program, time-activity data for the liver and precordium, blood radioactivity 2 min after i.v. injection of the radioligand, the association constant of Tc-99m-NGA-binding to HBP measured on human liver biopsies in vitro, and other patient-related parameters were put into a five-state non-linear model describing the pharmacokinetics of Tc-99m-NGA. By fitting the parameters of the model iteratively to the experimental data, an estimate of HBP concentration in the liver and of total liver blood flow was obtained. Using this model we studied 32 patients (53 +/- 11 years) with different clinical stages of alcoholic liver cirrhosis. Child B and Child C stage cirrhotic patients had a lower HBP concentration in the liver compared to control individuals (0.96 +/- 0.21-mu-mol l-1). The group with the most advanced cirrhosis (Child C stage) had a significantly lower HBP concentration (0.27 +/- 0.15-mu-mol l-1) than Child A patients (0.66 +/- 0.21-mu-mol l-1; P < 0.01) and Child B patients (0.53 +/- 0.18-mu-mol l-1; P < 0.05). In four patients with biopsy-proven liver fibrosis (0.84 +/- 0.20-mu-mol l-1) no difference in receptor concentration from normal individuals was estimated. Changes in liver blood flow were not significant between the groups. A direct comparison of HBP concentration estimated in vivo by Tc-99m-NGA functional imaging and HBP concentration measured in vitro on a surgically removed liver biopsy specimen from the same patient with a normal liver and liver cirrhosis showed good matching of these two values. The results suggest that in vivo estimation of HBP concentration in the liver by Tc-99m-NGA functional imaging might be a suitable method for determining liver cell mass.
引用
收藏
页码:507 / 517
页数:11
相关论文
共 23 条
[1]  
Haecki W., Bircher J., Preisig R.A., New look at the plasma disappearance of sulfobromo- phthalein (BSP): Correlation with BSP transport maximum and the hepatic plasma flow in man, J Lab Clin Med, 88, pp. 1019-1031, (1976)
[2]  
Paumgartner G., The handling of indocyanine green by the liver, Schweiz Med Wochenschr, 105, pp. 5-30, (1975)
[3]  
Miescher G., Paumgartner G., Preisig R., Portalsystemic spillover of bile acids: A study of mechanisms using ursodeoxycholic acid, Eur J Clin Invest, 13, pp. 439-445, (1975)
[4]  
Tygstrup N., Determination of hepatic elimination (Lm) of galactose by single injection, Scand J Clin Lab Invest, 18, pp. 18-125, (1966)
[5]  
Andreasen P.B., Ranek L., Statland B.E., Tygstrup N., Clearance of antipyrine - dependence of quantitative liver function, Eur J Clin Invest, 4, pp. 129-134, (1974)
[6]  
Bircher J., Kupfer A., Gikalow J., Preisig R., Aminopyrine demethylation measured by breath analysis in cirrhosis, Clin Pharmacol Ther, 20, pp. 484-492, (1974)
[7]  
Wang T., Kleber G., Stellaard F., Paumgartner G., Caffeine elimination: A test of liver function, Klin Wschr, 63, pp. 1124-1128, (1974)
[8]  
Vera D.R., Krohn K.A., Scheibe P.O., Stadalnik R.C., Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system, IEEE Trans Biomed Eng BME, 32, pp. 312-322, (1986)
[9]  
Vera D.R., Stadalnik R.C., Krohn K.A., Tc-99m galactosyl-neoglycoalbumin: Preparation and preclinical studies, J Nad Med, 26, pp. 1157-1167, (1985)
[10]  
Vera D.R., Kron K.A., Stadalnik R.C., Tc-99m-galactosylneoglycoalbumin: In vivo characterization of receptor-mediated binding to hepatocytes, Radiology, 151, pp. 191-196, (1984)